{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:56Z","timestamp":1791049556241,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.maturitas.2009.07.015","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T06:13:11Z","timestamp":1251267191000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence"],"prefix":"10.1016","volume":"64","author":[{"given":"Helena M.","family":"Verkooijen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bouchardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vinh-Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Rapiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2009.07.015_bib1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM197606032942303","article-title":"Increasing incidence of endometrial cancer in the United States","volume":"294","author":"Weiss","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2009.07.015_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1532-5415.1972.tb00753.x","article-title":"The basic philosophy of estrogen maintenance","volume":"20","author":"Wilson","year":"1972","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.maturitas.2009.07.015_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.maturitas.2006.11.008","article-title":"Use of hormone replacement therapy (HRT) among women aged 45\u201364 years in the German EPIC-cohorts","volume":"56","author":"Nagel","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2009.07.015_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-5122(99)00094-8","article-title":"Evaluation of hormone replacement therapy use by the sales figures","volume":"34","author":"Schaad","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2009.07.015_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ije\/dyn055","article-title":"Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections","volume":"37","author":"Krieger","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib6","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2009.01.016","article-title":"Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?","volume":"45","author":"Parkin","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0029-7844(94)00339-F","article-title":"Use of menopausal estrogens and medroxyprogesterone in the United States, 1982\u20131992","volume":"85","author":"Wysowski","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2009.07.015_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2009.07.015_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2009.07.015_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2009.07.015_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","article-title":"The use of estrogens and progestins and the risk of breast cancer in postmenopausal women","volume":"332","author":"Colditz","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2009.07.015_bib13","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2009.07.015_bib14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/aje\/kwn090","article-title":"Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study","volume":"167","author":"Prentice","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib15","doi-asserted-by":"crossref","first-page":"909s","DOI":"10.1158\/1078-0432.909s.11.2","article-title":"Estrogen, estrogen plus progestin therapy, and risk of breast cancer","volume":"11","author":"Colditz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.maturitas.2009.07.015_bib16","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X","article-title":"Changing incidence rate of invasive lobular breast carcinoma among older women","volume":"88","author":"Li","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.11032","article-title":"Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland","volume":"104","author":"Verkooijen","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijc.11309","article-title":"Increase in lobular breast cancer incidence in Switzerland","volume":"107","author":"Levi","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib19","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/cncr.20250","article-title":"Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study","volume":"100","author":"Tjonneland","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib20","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O","article-title":"Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women","volume":"88","author":"Li","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib21","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long durations and different regimens of hormone therapy and risk of breast cancer","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2009.07.015_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.287.6.734","article-title":"Hormone replacement therapy in relation to breast cancer","volume":"287","author":"Chen","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2009.07.015_bib23","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.10984","article-title":"Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma","volume":"95","author":"Daling","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib24","first-page":"593","article-title":"Postmenopausal estrogen and progestin use in relation to breast cancer risk","volume":"11","author":"Newcomb","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.maturitas.2009.07.015_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.329.7464.477","article-title":"Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study","volume":"329","author":"Banks","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2009.07.015_bib26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1158\/1055-9965.EPI-09-0002","article-title":"Menopausal hormone therapy and risk of clinical breast cancer subtypes","volume":"18","author":"Slanger","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.maturitas.2009.07.015_bib27","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr2145","article-title":"Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study","volume":"10","author":"Rosenberg","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.maturitas.2009.07.015_bib28","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2007.13.4338","article-title":"Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer","volume":"26","author":"Fournier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.gme.0000172595.68648.16","article-title":"Recent reversal of trends in hormone therapy use in a European population","volume":"13","author":"Morabia","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2009.07.015_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2407-6-78","article-title":"Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy","volume":"6","author":"Bouchardy","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib31","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2004.04.156","article-title":"Mammographic screening is dramatically changing age-incidence data for breast cancer","volume":"22","author":"Hemminki","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9554-3","article-title":"Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations","volume":"107","author":"Verkooijen","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2009.07.015_bib33","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/humrep\/dei043","article-title":"Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review","volume":"20","author":"Dietel","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2009.07.015_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-009-0346-9","article-title":"Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg","author":"Vankrunkelsven","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2009.07.015_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/djk088","article-title":"Breast cancer decline mirrors fall in hormone use, spurs both debate and research","volume":"99","author":"McNeil","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2009.07.015_bib36","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1200\/JCO.2006.08.6504","article-title":"Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence","volume":"24","author":"Clarke","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2009.07.015_bib38","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/jnci\/djm111","article-title":"Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population","volume":"99","author":"Kerlikowske","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2009.07.015_bib39","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2007.11.4132","article-title":"Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004","volume":"25","author":"Robbins","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib40","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","article-title":"Breast cancer incidence, 1980\u20132006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status","volume":"99","author":"Glass","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2009.07.015_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5694\/j.1326-5377.2008.tb01821.x","article-title":"Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia","volume":"188","author":"Canfell","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.maturitas.2009.07.015_bib42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(08)61255-6","article-title":"Declining breast cancer incidence and decreased HRT use","volume":"372","author":"Kumle","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2009.07.015_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-007-9566-z","article-title":"Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy","volume":"107","author":"Katalinic","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2009.07.015_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2009.07.015_bib45","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/bcr1839","article-title":"Recent breast cancer trends among Asian\/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype","volume":"9","author":"Hausauer","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.maturitas.2009.07.015_bib46","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr1672","article-title":"Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women","volume":"9","author":"Jemal","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.maturitas.2009.07.015_bib47","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/cncr.22723","article-title":"Reported drop in mammography: is this cause for concern?","volume":"109","author":"Breen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib48","first-page":"E1","article-title":"Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006","volume":"96","author":"Seradour","year":"2009","journal-title":"Bull Cancer"},{"key":"10.1016\/j.maturitas.2009.07.015_bib49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ncponc1113","article-title":"What caused the decline in US breast cancer incidence?","volume":"5","author":"Thorat","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.maturitas.2009.07.015_bib50","first-page":"511","article-title":"A decline in breast-cancer incidence","volume":"357","author":"Cady","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2009.07.015_bib51","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","article-title":"Breast cancer","volume":"365","author":"Veronesi","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2009.07.015_bib52","unstructured":"For Women. FDA\u2014Protecting the health of women: 2009. Available from: http:\/\/www.fda.gov\/ForConsumers\/byAudience\/ForWomen\/default.htm."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512209002618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512209002618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:47:37Z","timestamp":1759913257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512209002618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0378512209002618"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2009.07.015","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2009.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}